Abstract
Background
Recently, there have been a few reports on the decrease in the incidence of severe Henoch-Schönlein purpura nephritis (HSPN) in Japan. To evaluate the incidence and the severity of HSPN, we examined the epidemiology and clinical manifestations of HSPN in Fukushima Prefecture over a 22-year period.
Methods
We enrolled 61 patients (Group 1) diagnosed with HSPN between 1987 and 1997 and a further 59 patients (Group 2) diagnosed with HSPN between 1998 and 2008. Epidemiology, clinical features, laboratory data, pathological findings, treatment and outcome were retrospectively compared between the two groups.
Results
The mean number of patients per 100,000 children per year was 3.5 ± 1.2 in Group 1 and 3.6 ± 0.8 in Group 2. The clinical manifestations and laboratory findings at onset were comparable between Groups 1 and 2. Pathological findings in Group 1 and Group 2 were classified as ISKDC grade IIIa in 16 (26%) and 14 cases (24%), grade IIIb in 26 (43%) and 27 cases (46%), grade IV in 5 (8%) and 6 cases (10%)), grade V in 1 (2%) and 5 cases (8%), and grade VI in 2 (3%) and 2 cases (3%), respectively. There were no inter-group differences in ISKDC classification or rate of crescentic formation.
Conclusions
Our findings suggest that the incidence of HSPN and the severity of HSPN in patients between 1987 and 1997 were similar to those in patients between 1998 and 2008 and that the number of patients with severe HSPN has not decreased.
Similar content being viewed by others
References
Habib R, Niaudet R, Levy M (1994) Schönlein-Henoch purpura nephritis and IgA nephropathy. Renal pathology with clinical and functional correlations, 2nd edn. Lippincott, Philadelphia, Tisher CC, Brenner BM; pp 427–523
Trapani S, Micheli A, Grisolia F et al (2005) Henoch-Schönlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 35:143–153
Fretzayas A, Sionti I, Moustaki M et al (2008) Henoch-Schönlein purpura: a long-term prospective study in Greek children. J Clin Rheumatol 14:324–331
Haycock GB (1998) The nephritis of Henoch-Schönlein purpura. Oxford Textbook of Nephrology, 2nd edn. Oxford University Press, Oxford, Cameron JS pp 585–612
Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 12:238–243
Watanabe T, Takahashi S, Nakajo S et al (1996) Pathological improvement of IgA nephropathy and Henoch-Schönlein purpura nephritis with urokinase therapy. Acta Paediatr Jpn 38:622–628
Coppo R, Mazzucco G, Cagnoli L et al (1997) Henoch-Schönlein purpura Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Nephrol Dial Transplant 12:2277–2283
Counahan R, Winterborn MH, White RHR et al (1977) Prognosis of Henoch-Schönlein nephritis in children. Br Med J 2:11–14
Moriya S, Iitaka K, Koshino H et al (2000) Henoch-Schönlein purpura nephritis (HSPN) in children: comparison of the incidence and severity between two 12-year groups. Nippon Jinzo Gakkai Shi 42:36–40
Southwest Pediatric Nephrology Study Group (1985) A clinico-pathologic study of crescentic glomerulonephritis in 50 children: a report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27:450–458
National Heart, Lung and Blood Institute, Bethesda, Maryland (1987) Report of the second task force on blood pressure control in children. Pediatrics 79:1–25
White RHR (1994) Henoch-Schönlein nephritis. A disease with significant late sequelae. Nephron 68:1–9
Kawasaki Y, Suzuki J, Nozawa R et al (2003) Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis. Pediatrics 111:785–789
Kawasaki Y, Suzuki J, Suzuki H (2004) Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schönlein: a clinical and histopathological study. Nephrol Dial Transplant 19:858–864
Hattori M, Ito K, Konomoto T et al (1999) Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein Purpura nephritis in children. Am J Kidney Dis 33:427–433
Gardner-Medwin JMM, Dolezalova P, Cummins C et al (2002) Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197–1202
Stewan M, Savage JM, Bell B et al (1988) Long term renal prognosis of Henoch-Schönlein purpura in unselected childhood population. Eur J Pediatr 147:113–115
Nielsen HE (1988) Epidemiology of Schönlein-Henoch Purpura. Acu Pathol Scand 77:125–131
Iijima K, Ito-Kariya S, Nakamura H et al (1988) Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 12:244–248
Gianviti A, Trompeter RS, Barratt TM et al (1996) Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 75:186–190
Zaffanello M, Fanos V (2009) Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood. Pediatr Nephrol 24:1901–1911
Soylemezoglu O, Ozkaya O, Ozen S, Bakkaloglu A, Dusunsel R, Peru H, Cetinyurek A, Yidiz N, Donmez O, Buyan N, Mir S, Arisoy N, Gur-Guven A, Alpay H, Ekim M, Aksu N, Soylu A, Gok F, Poyrazoglu H, Sonmez F, Turkish Pediatric Vasculitis Study Group (2009) Henoch- Schönlein nephritis: a nationwide study. Nephron Clin Pract 112:c199–c204
Acknowledgments
The authors thank the members of the Department of Pediatrics for their valuable advice and comments in relation to this study. None of the authors have financial relationships with any companies with an interest in the subject matter of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawasaki, Y., Suyama, K., Yugeta, E. et al. The incidence and severity of Henoch-Schönlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan. Int Urol Nephrol 42, 1023–1029 (2010). https://doi.org/10.1007/s11255-009-9701-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-009-9701-3